BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6138463)

  • 1. [Comparative effects on renal function of 4 beta-blockers injected intravenously].
    Pozet N; Hadj Aissa AH; Labeeuw M; Zech P
    J Pharmacol; 1983; 14 Suppl 2():133-41. PubMed ID: 6138463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenoreceptors and renal function.
    Wallin JD
    J Clin Hypertens; 1985 Jun; 1(2):171-8. PubMed ID: 2873207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal effects of new beta-adrenergic receptor site blocking agents on renal function.
    Zech P; Pozet N; Labeeuw M; Sassard J; Bernheim J; Pellet M; Traeger J
    Proc Eur Dial Transplant Assoc; 1976; 12():203-9. PubMed ID: 6959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta blockers and renal function: a reappraisal.
    Epstein M; Oster JR
    J Clin Hypertens; 1985 Mar; 1(1):85-99. PubMed ID: 2873206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in renal function in the hours following an intravenous injection of acebutolol].
    Pozet N; Zech P; Pellet M; Traeger J
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3252-5. PubMed ID: 1219633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
    Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
    Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of renal function under chronic oral administration of labetalol.
    Labeeuw M; Zech P; Pozet N; Hadj-Aissa A; Traeger J
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):23-5. PubMed ID: 3557725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of some beta-adrenergic blocking drugs on the renal bloow flow in dogs.
    Abdel-Razzak M
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):227-34. PubMed ID: 23082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
    Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should beta-blockers be used to control hypertension in people with chronic kidney disease?
    Hart PD; Bakris GL
    Semin Nephrol; 2007 Sep; 27(5):555-64. PubMed ID: 17868793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
    Zech P; Pozet N; Sassard J; Vincent M
    Nouv Presse Med; 1980 Mar; 9(15):1087-90. PubMed ID: 7008020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute renal effects of beta-blockers.
    Zech P; Pozet N; Labeeuw M; Laville M; Hadj-Aissa A; Arkouche W; Poncet JF
    Am J Nephrol; 1986; 6 Suppl 2():15-9. PubMed ID: 2879466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative effects of seven beta adrenolytic agents on blood pressure after injection into the posterior hypothalamus of rats. The frequency heart and the plasma renin activity (author's transl)].
    Bentue-Ferrer D; Allain H; Van den Driessche J; Pape D; Reymann JM
    J Pharmacol; 1981; 12(2):161-77. PubMed ID: 6115097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
    Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
    J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.